About RTI Surgical (NASDAQ:RTIX)
RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:RTIX
CUSIP74975N10
Phone386-418-8888
Debt
Debt-to-Equity Ratio0.23%
Current Ratio3.50%
Quick Ratio1.39%
Price-To-Earnings
Trailing P/E Ratio74.17
Forward P/E Ratio44.00
P/E Growth2.97
Sales & Book Value
Annual Sales$279.56 million
Price / Sales0.97
Cash Flow$0.2655 per share
Price / Cash16.57
Book Value$2.99 per share
Price / Book1.47
Profitability
EPS (Most Recent Fiscal Year)$0.05
Net Income$6.27 million
Net Margins2.24%
Return on Equity2.88%
Return on Assets1.39%
Miscellaneous
Employees942
Outstanding Shares61,730,000
RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
How were RTI Surgical's earnings last quarter?
RTI Surgical (NASDAQ:RTIX) posted its earnings results on Thursday, March, 1st. The medical equipment provider reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.01. The medical equipment provider had revenue of $70.82 million for the quarter, compared to analysts' expectations of $70.16 million. RTI Surgical had a return on equity of 2.88% and a net margin of 2.24%. View RTI Surgical's Earnings History.
When is RTI Surgical's next earnings date?
Who are some of RTI Surgical's key competitors?
Some companies that are related to RTI Surgical include Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), BioCardia (BCDA), ReWalk Robotics (RWLK), NanoVibronix (NAOV), Helomics (AIPT), Allied Healthcare Products (AHPI), Bionik Laboratories (BNKL) and Avitar (AVTI).
Who are RTI Surgical's key executives?
RTI Surgical's management team includes the folowing people:
- Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 54)
- Mr. John N. Varela, Exec. VP of Global Operations (Age 51)
- Mr. Johannes Wynand Louw, VP and Controller
- Mr. Camille I. Farhat, CEO, Pres & Director (Age 48)
- Roxane Wergin, Director of Corp. Communications
Has RTI Surgical been receiving favorable news coverage?
Media coverage about RTIX stock has trended somewhat positive on Thursday, according to Accern. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.11 on Accern's scale. They also assigned press coverage about the medical equipment provider an impact score of 47.08 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of RTI Surgical?
Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RTI Surgical's stock price today?
One share of RTIX stock can currently be purchased for approximately $4.40.
How big of a company is RTI Surgical?
RTI Surgical has a market capitalization of $274.71 million and generates $279.56 million in revenue each year. The medical equipment provider earns $6.27 million in net income (profit) each year or $0.05 on an earnings per share basis. RTI Surgical employs 942 workers across the globe.
How can I contact RTI Surgical?
RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]
MarketBeat Community Rating for RTI Surgical (RTIX)
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
RTI Surgical (NASDAQ:RTIX) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for RTI Surgical in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | N/A | N/A |
| Consensus Rating Score: | 3.00 | 3.00 | N/A | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
RTI Surgical (NASDAQ:RTIX) Consensus Price Target History
RTI Surgical (NASDAQ:RTIX) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 3/2/2018 | Craig Hallum | Upgrade | Hold -> Buy | | High |  |
(Data available from 4/26/2016 forward)
RTI Surgical (NASDAQ:RTIX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
RTI Surgical (NASDAQ RTIX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.90%
Institutional Ownership Percentage: 69.77%
RTI Surgical (NASDAQ RTIX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/21/2017 | Nicholas J Valeriani | Director | Buy | 5,500 | $4.70 | $25,850.00 | 47,754 | |
| 8/11/2017 | John N Varela | EVP | Buy | 12,000 | $4.85 | $58,200.00 | 47,998 | |
| 5/18/2017 | Camille Farhat | CEO | Buy | 61,693 | $4.65 | $286,872.45 | | |
| 5/8/2017 | Shirley A Weis | Director | Buy | 2,200 | $4.58 | $10,076.00 | 41,386 | |
| 5/5/2017 | Mark Stolper | Director | Buy | 5,000 | $4.57 | $22,850.00 | 11,331 | |
| 5/4/2017 | Nicholas J Valeriani | Director | Buy | 5,500 | $4.60 | $25,300.00 | 25,770 | |
| 5/3/2017 | Kevin D Brandt | EVP | Buy | 33,130 | $4.52 | $149,747.60 | 126,215 | |
| 5/2/2017 | Thomas Mceachin | Director | Buy | 4,500 | $4.35 | $19,575.00 | 30,293 | |
| 3/2/2017 | Jonathon M Singer | Director | Buy | 10,000 | $3.79 | $37,900.00 | 30,270 | |
| 2/17/2017 | Camille Farhat | CEO | Buy | 83,000 | $3.44 | $285,520.00 | | |
| 11/5/2013 | Julianne Bowler | Director | Buy | 5,244 | $2.89 | $15,155.16 | 58,151 | |
| 10/31/2013 | Thomas F Rose | COO | Buy | 3,000 | $2.97 | $8,910.00 | | |
(Data available from 1/1/2013 forward)
RTI Surgical (NASDAQ RTIX) News Headlines
| Source: |
|
RTI Surgical (NASDAQ:RTIX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
RTI Surgical (NASDAQ:RTIX) Income Statement, Balance Sheet and Cash Flow Statement
RTI Surgical (NASDAQ RTIX) Stock Chart for Thursday, April, 26, 2018
Loading chart…
